Janssen Signs Licensing Agreement with Vedanta for IBD Treatment Development
IBD News, News
Philadelphia-based Janssen Biotech, Inc., a biotechnology company with a focus on developing diagnostic assays using monoclonal antibody technology, has just signed a strategic licensing agreement with Vedanta Biosciences, an expert in microbiology ... Read more